5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation

Teresa Field, Janelle Perkins, Yifan Huang, +10

Bone Marrow Transplantation

Hematological MalignancyTransplantationHematologyMedicineCell Transplantation +1

A Randomized Phase II Trial Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate for Acute Graft-versus-Host Disease Prophylaxis

Janelle Perkins, Teresa Field, Jongphil Kim, +10

Biology of Blood and Marrow Transplantation

Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization

Joseph Pidala, J. Kim, Michael J. Schell, +18

Bone Marrow Transplantation

EthnicityHistocompatibilityTransplant RejectionTransplantationHuman Leukocyte Antigen +10

A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation

Joseph Pidala, J. Kim, Heather Jim, +16

Haematologica

Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation

Ernesto Ayala, John Greene, Ramón L. Sandin, +5

Bone Marrow Transplantation

Cell TherapyTransplantationCmv InfectionImmunologyAntiviral Therapy +6

Sirolimus for treatment of steroid-refractory acute graft-versus-host disease

Daanish Hoda, Joseph Pidala, Norma Salgado-Vila, +14

Bone Marrow Transplantation

TransplantationAutoimmune DiseaseImmunologyGraft SurvivalImmunotherapy +3

Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients

Julie M. Cessna, Heather Jim, Steven K. Sutton, +9

Journal of Psychosomatic Research

Quality Of LifePsychometric PropertiesFatigue ManagementMedicinePatient-reported Outcome +6

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

Joseph Pidala, J. Kim, Claudio Anasetti, +4

Haematologica

Maximally Tolerated Busulfan Systemic Exposure in Combination with Fludarabine as Conditioning before Allogeneic Hematopoietic Cell Transplantation

Janelle Perkins, Jongphil Kim, Claudio Anasetti, +8

Biology of Blood and Marrow Transplantation

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

Joseph Pidala, Jongphil Kim, Claudio Anasetti, +6

Journal of Hematology & Oncology

Pharmacokinetic TargetingAgvhd ProphylaxisImmunologyTransplantation MedicinePharmacotherapy +15